ALKS vs ORCL · P/E 14, rev $1.56B vs P/E 31, rev $67.36B
Alkermes Plc (ALKS) versus Oracle Corporation (ORCL) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Safra Catz.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. Revenue was up 17.3% from 2025-05-31 to 2026-05-31. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Not investment advice. Open the ALKS and ORCL stock pages for the full models.
Not investment advice.